Icecure Medical Ltd (ICCM) is expecting -11.12% growth in the next quarter: What can investors do to maximize their returns?

On Friday, Icecure Medical Ltd (NASDAQ: ICCM) opened higher 6.74% from the last session, before settling in for the closing price of $0.84. Price fluctuations for ICCM have ranged from $0.47 to $1.63 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 2.44%. Company’s average yearly earnings per share was noted 26.39% at the time writing. With a float of $40.31 million, this company’s outstanding shares have now reached $58.70 million.

Let’s determine the extent of company efficiency that accounts for 72 employees. In terms of profitability, gross margin is 42.77%, operating margin of -479.77%, and the pretax margin is -467.37%.

Icecure Medical Ltd (ICCM) Insider Activity

A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Icecure Medical Ltd is 41.31%, while institutional ownership is 0.37%.

Icecure Medical Ltd (ICCM) Earnings and Forecasts

If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.08 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.08) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 26.39% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.41% during the next five years compared to 2.44% growth over the previous five years of trading.

Icecure Medical Ltd (NASDAQ: ICCM) Trading Performance Indicators

Check out the current performance indicators for Icecure Medical Ltd (ICCM). In the past quarter, the stock posted a quick ratio of 0.88. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 22.12.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.18 in one year’s time.

Technical Analysis of Icecure Medical Ltd (ICCM)

Looking closely at Icecure Medical Ltd (NASDAQ: ICCM), its last 5-days average volume was 0.96 million, which is a jump from its year-to-date volume of 0.64 million. As of the previous 9 days, the stock’s Stochastic %D was 62.11%.

During the past 100 days, Icecure Medical Ltd’s (ICCM) raw stochastic average was set at 30.98%, which indicates a significant decrease from 53.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0649 in the past 14 days, which was lower than the 0.0729 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.9819, while its 200-day Moving Average is $1.0742. However, in the short run, Icecure Medical Ltd’s stock first resistance to watch stands at $0.9289. Second resistance stands at $0.9594. The third major resistance level sits at $0.9989. If the price goes on to break the first support level at $0.8589, it is likely to go to the next support level at $0.8194. Should the price break the second support level, the third support level stands at $0.7889.

Icecure Medical Ltd (NASDAQ: ICCM) Key Stats

There are currently 58,697K shares outstanding in the company with a market cap of 61.71 million. Presently, the company’s annual sales total 3,290 K according to its annual income of -15,320 K. Last quarter, the company’s sales amounted to 730 K and its income totaled -3,590 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.